TRITIATION OF BETA CYCLODEXTRIN: HEPARIN
TRITIATION OF BETA CYCLODEXTRIN: HEPARIN
批准号:
6220458
负责人:
HIROMI MORIMOTO
金额:
$0.26万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-01 至 2000-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A Basic Compositional Requirement of Agents Having Heparin-Like
Cell-Modulating Activities Heparin has been recognized as possessing a
large variety of cell-modulating activities. Using compositionally
simple, structurally rigid, and low molecular weight saccharide
molecules (cyclodextrins), we demonstrated that these activities
depend primarily on a single, gross compositional parameter: a
minimum intramolecular density of neighboring anionic (sulfate)
groups. This same critical parameter is shown to be involved in
achieving cell-modulating behaviors as diverse as angiogenesis,
endothelial proliferation, inhibition of smooth muscle cell growth,
and cell protection against virus invasion. Physical chemical
evidence is presented that associates this property with multi-ionic
complex formation between the clusters of anionic and cationic sites
on the complexing partners. These observations revive early
suggestions of the decisive role of electrostatic complexation
capabilities of glycosaminoglycans like heparin. Taken together with
numerous observations on hepatinoids and other agents reported in
diverse specialized fields of cell biology and medicine, they provide
evidence that molecular agents of critical anionic (sulfate) density
(MACADs) represent a broad class of molecules that, in contrast to
proteins, do not rely on structural detail for their cell biological
activities, but function by ionic complexation with proteinic agents
(e.g. growth factors), thereby modifying their structure specific
activities. Tritium labelling of these materials will greatly
facilitate studies of the mechanism of action. A first attempt at
labelling by metal-catalyzed exchange into the final molecule was
unsuccessful. As a second approach, a precursor suitable for hydride
reduction is being prepared, and we expect to carry out those
reactions during the coming grant period.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TRITIUM LABELLING OF APTAMERS: MACULAR DEGENERATION
-
批准号:6500505
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:HIROMI MORIMOTO
-
依托单位:
SYNTHESIS OF SPECIFICALLY LABELLED NICOTINE COMPOUND: PARKINSON'S & ALZHEIMER'S
-
批准号:6500509
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:HIROMI MORIMOTO
-
依托单位:
STEREOCHEMISTRY OF POLYKETIDE BIOSYNTHESIS
-
批准号:6500504
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:HIROMI MORIMOTO
-
依托单位:
TRITIUM LABELLING OF ALZHEIMER DRUG
-
批准号:6500510
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:HIROMI MORIMOTO
-
依托单位:
MIXED WASTE DILEMMA IN UNITED STATES OF AMERICA: LOW LEVEL RADIOACTIVE WASTE
-
批准号:6500536
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:HIROMI MORIMOTO
-
依托单位:
METHYL & METHYLENE ELIMINAT STEREOCHEMISTRY IN EPI ARISTOLOCHENE BIOSYNTHESIS
-
批准号:6500528
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:HIROMI MORIMOTO
-
依托单位:
TRITIUM LABELLING OF SEROTONIN ANALOG: GASTROINTESTINAL DISORDER & ULCERS
-
批准号:6500506
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:HIROMI MORIMOTO
-
依托单位:
TRITIUM LABELLING OF NERVE REGENERATION DRUG
-
批准号:6500508
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:HIROMI MORIMOTO
-
依托单位:
TRITIUM LABELLING OF RETINOIC ACID ANALOG: PSORIASIS & CANCER CHEMOTHERAPY
-
批准号:6500512
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:HIROMI MORIMOTO
-
依托单位:
ACTIVATION, PHARMACOKINETICS, & MECHANISM OF ACTION OF BCI 101, LR 110 & LR 103
-
批准号:6500514
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:HIROMI MORIMOTO
-
依托单位:
TRITIUM LABELLING OF DOPAMINE AGONIST: SCHIZOPHRENIA
-
批准号:6500519
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:HIROMI MORIMOTO
-
依托单位:
TRITIUM LABELLING OF LIGAND FOR MELATONIN RECEPTOR: SCHIZOPHRENIA
-
批准号:6500513
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:HIROMI MORIMOTO
-
依托单位:
TRITIATION OF MANDUCA SEXTA ADIPOKINETIC HORMONES
-
批准号:6500529
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:HIROMI MORIMOTO
-
依托单位:
TRITIUM LABELLING OF PHEROMONES: INSECT HYDROCARBONS & ODORANTS
-
批准号:6500516
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:HIROMI MORIMOTO
-
依托单位:
TRITIATION OF OPIOID PEPTIDES
-
批准号:6500517
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:HIROMI MORIMOTO
-
依托单位:
TRITIATION OF CEMBRANOIDS: NICOTINIC ACETYLCHOLINE RECEPTOR
-
批准号:6500527
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:HIROMI MORIMOTO
-
依托单位:
TRITIATION OF OPIOID PEPTIDES: NEUROPEPTIDES
-
批准号:6500507
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:HIROMI MORIMOTO
-
依托单位:
TRITIATION OF ANILINO GERANYL PYROPHOSPHATE
-
批准号:6500530
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:HIROMI MORIMOTO
-
依托单位:
TRITIATION OF BETA CYCLODEXTRIN: HEPARIN
-
批准号:6500531
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:HIROMI MORIMOTO
-
依托单位:
TRITIUM LABELLING OF RETINOIC ACID ANALOG: PSORIASIS & CANCER CHEMOTHERAPY
-
批准号:6220439
-
项目类别:
-
资助金额:$1.56万
-
财政年份:1998
-
负责人:HIROMI MORIMOTO
-
依托单位:
海外基金